Prevalence and clinical significance of clinically evident portal hypertension in patients with hepatocellular carcinoma undergoing transarterial chemoembolization

BACKGROUND: Clinically evident portal hypertension (CEPH) was previously identified as a prognostic factor for patients with hepatocellular carcinoma (HCC). However, little is known about the prognostic influence of CEPH on the long‐term outcome of patients with HCC undergoing transarterial chemoemb...

Descripción completa

Detalles Bibliográficos
Autores principales: Müller, Lukas, Hahn, Felix, Mähringer‐Kunz, Aline, Stoehr, Fabian, Gairing, Simon Johannes, Foerster, Friedrich, Weinmann, Arndt, Galle, Peter Robert, Mittler, Jens, Pinto dos Santos, Daniel, Pitton, Michael Bernhard, Düber, Christoph, Fehrenbach, Uli, Auer, Timo Alexander, Gebauer, Bernhard, Kloeckner, Roman
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Hepatobiliary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830270/
https://www.ncbi.nlm.nih.gov/pubmed/34918471
http://dx.doi.org/10.1002/ueg2.12188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8830270/
https://www.ncbi.nlm.nih.gov/pubmed/34918471
http://dx.doi.org/10.1002/ueg2.12188

Ejemplares similares